sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
3-Jul-2015 08:24
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 151-175 out of 1064.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>

Public Release: 21-Apr-2015
Fourth Global Forum on TB Vaccines
New research points to elderly as growing contributor to tuberculosis in China
A major contributor to the number of tuberculosis infections and cases in China will likely be the elderly over the next decades, requiring a refocus in efforts to control a disease affecting millions in China, according to preliminary new research presented today at the Fourth Global Forum on TB Vaccines in Shanghai. Researchers from the LSHTM found that developing a 'post-infection' vaccine could reduce overall TB rates in China by almost a third by 2050.

Contact: Ellen Wilcox
ewilcox@aeras.org
240-422-2145
Burness Communications

Public Release: 20-Apr-2015
American Journal of Tropical Medicine and Hygiene
Notre Dame researchers detecting low quality antimalarial drugs with a lab-on-paper
Access to high-quality medicine is a basic human right, but over four billion people live in countries where many medications are substandard or fake. Marya Lieberman of the Department of Chemistry and Biochemistry at the University of Notre Dame and Abigail Weaver a postdoctoral associate in the University's Department of Civil Engineering and Environmental and Earth Sciences took up the challenge of how people in developing countries could detect low quality antimalarial drugs without expensive equipment and without handling dangerous chemicals.

Contact: Marya Lieberman
mlieberm@nd.edu
574-631-4665
University of Notre Dame

Public Release: 20-Apr-2015
American Journal of Tropical Medicine and Hygiene
Global pandemic of fake medicines poses urgent risk, scientists say
Poor quality medicines are an urgent threat that could undermine decades of successful efforts to combat HIV/AIDS, malaria and TB, according to the editors of a journal supplement published today. Scientists report up to 41 percent of specimens failed to meet quality standards in global studies of about 17,000 drug samples. Seventeen articles are included in the supplement 'The Global Pandemic of Falsified Medicines,' published by The American Journal of Tropical Medicine and Hygiene.
NIH/Fogarty International Center, Bill & Melinda Gates Foundation, New Venture Fund

Contact: Ann Puderbaugh
ann.puderbaugh@nih.gov
301-402-8614
NIH/Fogarty International Center

Public Release: 20-Apr-2015
American Journal of Tropical Medicine and Hygiene
Fake malaria drugs not as common as previously reported
A rigorous analysis of antimalarial drug quality conducted in Cambodia and Tanzania found no evidence of fake medicines, according to new research from the London School of Hygiene & Tropical Medicine.
Bill and Melinda Gates Foundation

Contact: Katie Steels
press@lshtm.ac.uk
44-020-792-72802
London School of Hygiene & Tropical Medicine

Public Release: 20-Apr-2015
Proceedings of the National Academy of Sciences
Cancer drug shows promise as cure for hepatitis B
Australian scientists have found a potential cure for hepatitis B virus infections, with a promising new treatment proving 100 percent successful in eliminating the infection in preclinical models. Australian patients are now the first in the world to have access to the potential treatment -- a combination of an antiviral drug and an anti-cancer drug -- which is in phase 1/2a clinical trials in Melbourne, Perth and Adelaide.
National Health and Medical Research Council, Australian Research Council, Victorian Government

Contact: Alan Gill
gill.a@wehi.edu.au
61-393-452-719
Walter and Eliza Hall Institute

Public Release: 19-Apr-2015
American Association for Cancer Research Annual Meeting 2015
Broccoli sprout extract promising for head and neck cancer prevention
Broccoli sprout extract protects against oral cancer in mice and proved tolerable in a small group of healthy human volunteers, the University of Pittsburgh Cancer Institute, partner with UPMC CancerCenter, announced today at the American Association for Cancer Research (AACR) Annual Meeting in Philadelphia.
NIH/National Cancer Institute

Contact: Allison Hydzik
hydzikam@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences

Public Release: 17-Apr-2015
Antimicrobial Agents and Chemotherapy
New genetic mutation could signal start of malaria drug resistance in Africa
Early indicators of the malaria parasite in Africa developing resistance to the most effective drug available have been confirmed, according to new research from the London School of Hygiene & Tropical Medicine.

Contact: Katie Steels
press@lshtm.ac.uk
44-020-792-72802
London School of Hygiene & Tropical Medicine

Public Release: 16-Apr-2015
Science
Subsidies key in improving sanitation, new study finds
For years, governments and major development institutions have vigorously debated how to address poor sanitation in developing countries, which causes 280,000 deaths per year worldwide. A new study released in Science today found that in Bangladesh, a community-motivation model that has been used in over 60 countries to increase use of hygienic latrines had no effect, but that latrine coverage expands substantially when that model is combined with subsidies for hygienic latrines targeted to the poor.

Contact: Heidi McAnnally-Linz
hlinz@poverty-action.org
203-974-2976
Innovations for Poverty Action

Public Release: 16-Apr-2015
PLOS Neglected Tropical Diseases
160 people die of rabies every day, says major new study
A global study on canine rabies, published April 16, 2015, has found that 160 people die every single day from the disease. The report is the first study to consider the impact in terms of deaths and the economic costs of rabies across all countries. Even though the disease is preventable, 59,000 people die every year of rabies transmitted by dogs, and the disease costs global economies $8.6 billion US.
UBS Optimus Foundation, Wellcome Trust

Contact: Kevin Doran
pr@rabiesalliance.org
44-791-469-9155
Global Alliance for Rabies Control

Public Release: 15-Apr-2015
Canada, India fund 5 innovations to improve health in India, with focus on mothers and children
Canada and India today announced investments of CDN $2.5 million in five innovations in India aimed primarily at improving maternal, newborn and child health -- Canada's flagship development priority. Canadian government-funded Grand Challenges Canada and the Grand Challenges India initiative of the Government of India, made the joint announcement during the official visit to Canada of India's Prime Minister Narendra Modi.
Grand Challenges Canada, Grand Challenges India

Contact: Lode Roels
lode.roels@grandchallenges.ca
647-328-2021
Grand Challenges Canada

Public Release: 15-Apr-2015
DNA and Cell Biology
Fighting tuberculosis using the body's natural anti-microbial processes
A new approach to combatting tuberculosis would take advantage of a complex, natural process called autophagy that the human body uses to recycle nutrients, remove damaged cell components, eliminate invading bacteria, and respond to inflammation. In addition to its potential as a novel therapeutic strategy, autophagy is the focus of increasing research to understand the role it may have in a range of diseases including heart disease, diabetes, and age-related neurodegenerative disorders such as Alzheimer's disease.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 14-Apr-2015
The Journal of Alternative and Complementary Medicine
Antimalarial tea -- from herbal remedy to licensed phytomedicine
Malaria is a critical health problem in West Africa, where traditional medicine is commonly used alongside modern healthcare practices. An herbal remedy derived from the roots of a weed, which was traditionally used to alleviate malarial symptoms, was combined with leaves and aerial portions from two other plants with antimalarial activity, formulated as a tea, and eventually licensed and sold as an antimalarial phytomedicine.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 14-Apr-2015
Journal of Psychiatric Research
Wristband that measures rest, activity schedule may help predict response to antidepressants
A wristband that records motion throughout a 24-hour cycle may be an inexpensive, safe way to determine which patients with major depressive disorder will respond best to commonly prescribed drugs such as Prozac.

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 14-Apr-2015
PLOS Medicine
How best to test Ebola treatment
An unconventional clinical trial design might have advantages over classical trials for testing treatments for Ebola virus disease (EVD), suggests a study published this week in PLOS Medicine. The work of an international team led by John Whitehead of Lancaster University, UK and Ben Cooper of Oxford University, UK, provides much-needed data to inform a debate on the scientific and ethical justification for non-randomized EVD trials.
Wellcome Trust, European Union, Medical Research Council, Department for International Development

Contact: Hugh O' Brien
medicinepress@plos.org
PLOS

Public Release: 13-Apr-2015
Health Affairs
The cost and quality of cancer care in Health Affairs' April issue
The April issue of Health Affairs contains a cluster of papers focusing on the cost and quality of cancer care. Other subjects covered in the issue: health care payment reform and the diminished number of uninsured young adults. Publication of the cancer studies in the April issue was supported by Precision Health Economics and the Celgene Corporation.

Contact: Sue Ducat
sducat@projecthope.org
301-841-9962
Health Affairs

Public Release: 13-Apr-2015
NIH, South African Medical Research Council award $8 million in HIV, TB grants
NIH and the South African Medical Research Council are awarding 31 grants to US and South African scientists to support research targeting HIV/AIDS, tuberculosis and HIV-related co-morbidities and cancers. The awards, which total $8 million in first-year funding, are the first to be issued through the South Africa-US Program for Collaborative Biomedical Research.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Kathy Stover
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 9-Apr-2015
Cell Reports
New Ebola study points to potential drug target
Opening the door to potential treatments for the deadly Ebola virus, scientists led by Washington University School of Medicine in St. Louis have shown that interfering with its replication can stop the virus in its tracks.
US Department of Defense, National Institutes of Health

Contact: Diane Duke Williams
williamsdia@wustl.edu
314-286-0111
Washington University School of Medicine

Public Release: 8-Apr-2015
Nature
UTMB researchers develop Ebola vaccine effective in a single dose
An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year. These findings are detailed in the new edition of Nature.
National Institutes of Health, UTMB Department of Microbiology and Immunology

Contact: Donna Ramirez
donna.ramirez@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston

Public Release: 8-Apr-2015
Science Translational Medicine
Plotting the elimination of dengue
Researchers at the University of Melbourne along with international collaborators are using a novel way to block the dengue virus in Aedes aegypti mosquitoes using the insect bacterium, Wolbachia and have for the first time provided projections of its public health benefit.

Contact: Anne Rahilly
arahilly@unimelb.edu.au
61-390-355-380
University of Melbourne

Public Release: 8-Apr-2015
International Journal of Public Health
Case study Cabo Verde: Simulation offers policy Rx for curbing HIV
The African archipelago nation of Cabo Verde could bring its HIV epidemic under control within 10 years by ramping up a combination of four interventions already underway, according to projections from a sophisticated computer model led by Brown University public health researchers. Much of the progress could be achieved, the model predicts, by focusing the effort just on the most at-risk populations.
National Institutes of Health

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 8-Apr-2015
Nature
In first human study, new antibody therapy shows promise in suppressing HIV infection
In the first results to emerge from HIV patient trials of a new generation of so-called broadly neutralizing antibodies, Rockefeller University researchers have found the experimental therapy can dramatically reduce the amount of virus present in a patient's blood.
Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery, NIH/Cooperative Centers on Human Immunology, National Center for Advancing Translational Science, Robertson Foundation, NIH/National Cancer Institute

Contact: Zach Veilleux
zveilleux@rockefeller.edu
212-327-8982
Rockefeller University

Public Release: 7-Apr-2015
Journal of Allergy and Clinical Immunology
Asthma rates among black youth are similarly high in urban, rural communities
Asthma rates among black youth living in urban Detroit and rural Georgia are essentially the same, researchers report, a finding that conflicts with the widely held theory that city life is a risk factor, and pointing instead toward poverty.

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 7-Apr-2015
Journal of Clinical Investigation
Gene variant and environment can boost severity of respiratory syncytial virus
A particular genetic mutation combined with an urban environment increases the risk of severe disease in children infected with respiratory syncytial virus, an international team of investigators has found.
Bill & Melinda Gates Foundation, National Institutes of Health

Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center

Public Release: 7-Apr-2015
PLOS Medicine
Epidemiology of HIV-1 transmitted drug resistance
Only a limited number of surveillance drug-resistance mutations are responsible for most instances of non-nucleoside reverse transcriptase inhibitor- and nucleoside reverse transcriptase inhibitor-associated resistance, and most strains of HIV-1 transmitted drug resistance in sub-Saharan Africa and south/southeast Asia arose independently, according to a study led by Soo-Yon Rhee of Stanford University, published this week in PLOS Medicine.
National Institutes of Health, Bill & Melinda Gates Foundation, Centers for AIDS Research

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Public Release: 7-Apr-2015
PLOS Medicine
Stanford-led study finds limited mutations involved in transmission of drug-resistant HIV
In the largest study of its kind to date, researchers at Stanford University School of Medicine and their colleagues have found that worldwide only a limited number of mutations are responsible for most cases of transmission of drug-resistant HIV.
National Institutes of Health, Bill & Melinda Gates Foundation, Center for AIDS Research

Contact: Ruthann Richter
richter1@stanford.edu
650-725-8047
Stanford University Medical Center

Showing releases 151-175 out of 1064.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>